Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers

Next Previous
X
Search
Trial Profile

A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers

Status: Recruiting
Phase of Trial: Phase I

Latest Information Update: 08 Aug 2024

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs NXP 900 (Primary)
  • Indications Solid tumours
  • Focus Adverse reactions; First in man
  • Sponsors Nuvectis Pharma

    • Most Recent Events

    • 06 Aug 2024 According to a Nuvectis Pharma media release, three cohorts have been completed with no reports of dose limiting toxicities.
    • 19 Mar 2024 According to a Nuvectis Pharma media release, data from this study will be presented at the 2024 American Association for Cancer Research Meeting (2024 AACR), taking place from April 5th to April 10th in San Diego, California.
    • 12 Sep 2023 According to a Nuvectis media release, the company has initiated this study.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top